Sarborg Limited

About Sarborg Limited

Sarborg is a technology-driven company focused on integrating AI agents, cybernetics, and machine learning to optimize decision-making processes in the pharmaceutical industry. Its primary mission is to enhance drug repurposing for pharmaceutical companies, improving asset portfolio management and increasing the probability of success in clinical trials through innovative algorithmic strategies.

Products & Services

Multi-Agent Platform:A proprietary platform that uses AI agents and cybernetics to identify high-potential drug assets for repurposing, significantly reducing discovery timelines to less than six weeks.

Signature Agent:An AI-driven tool that analyzes drug and disease signatures to generate compatibility scores, identifying repurposing, combination, and discovery opportunities with high precision.

Client Services:Tailored AI and cybernetics-driven solutions for pharmaceutical companies, including drug repurposing, asset management, and clinical trial optimization, offered for a fee or equity.

Equity Partnerships:Collaborations with mid-sized pharmaceutical companies involving AI-driven portfolio analysis, leading to equity stakes or economic benefits on specific assets.

Owned Intellectual Property:Development of new IP through AI agent-based identification and solid-form engineering, followed by out-licensing for royalties and milestone payments.

Specialties

Artificial Intelligence Cybernetics Machine Learning Drug Repurposing Pharmaceutical R&D Asset Portfolio Management Clinical Trial Optimization Solid-Form Engineering Intellectual Property Generation

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Seed T: - FT: Seed	A: 10000000 MR: - FA: $10 million FAN: 10000000	D: 2025-08-27 FD: 2025-08-27	1 investors

Seed Latest

2025-08-27

$10.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Andrew Regan

Chief Executive

H

Hitesh Sanganee

Co-Founder

B

Ben Readhead

Edson Endowed Professor of Dementia Research

D

David Weston

Life Sciences Strategy leader

View 1 more team members with Pro

Unlock Full Team Directory

Recent News

Sarborg Limited Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised